Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 130 articles:
HTML format



Single Articles


    June 2021
  1. YAMADA T, Haruki S, Minami Y, Numata M, et al
    The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00131.
    PubMed     Abstract available


  2. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed     Abstract available


  3. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available


  4. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed     Abstract available


    May 2021
  5. HITOMI Y, Nagatomo Y, Yukino M, Yumita Y, et al
    Characterization of tolvaptan response and its impact on the outcome for patients with heart failure.
    J Cardiol. 2021 May 23. pii: S0914-5087(21)00111.
    PubMed     Abstract available


    April 2021
  6. NAKAMURA T, Tsujita K
    Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
    J Cardiol. 2021 Apr 1. pii: S0914-5087(21)00059.
    PubMed     Abstract available


    February 2021
  7. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
    Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
    J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
    PubMed     Abstract available


  8. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
    Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
    J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
    PubMed     Abstract available


  9. SOEDA T, Okura H, Saito Y, Nakao K, et al
    Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
    J Cardiol. 2021;77:139-146.
    PubMed     Abstract available


  10. NAITO Y, Masuyama T, Ishihara M
    Iron and cardiovascular diseases.
    J Cardiol. 2021;77:160-165.
    PubMed     Abstract available


    January 2021
  11. FUJIMOTO W, Konishi A, Iwasaki M, Toh R, et al
    Precipitating factors and clinical impact of early rehospitalization for heart failure in patients with heart failure in Awaji Island, Japan.
    J Cardiol. 2021 Jan 5. pii: S0914-5087(20)30418.
    PubMed     Abstract available


  12. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
    Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
    J Cardiol. 2021;77:10-16.
    PubMed     Abstract available


  13. KANAMORI H, Naruse G, Yoshida A, Minatoguchi S, et al
    Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
    J Cardiol. 2021;77:30-40.
    PubMed     Abstract available


    December 2020
  14. TANAKA H, Yamauchi Y, Imanishi J, Hatani Y, et al
    Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
    J Cardiol. 2020 Dec 31. pii: S0914-5087(20)30417.
    PubMed     Abstract available


  15. NATANZON SS, Mazin I
    Author's reply: The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 4. pii: S0914-5087(20)30385.
    PubMed    


  16. IZUMIDA T, Imamura T
    The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 3. pii: S0914-5087(20)30386.
    PubMed    


  17. IZUMIDA T, Imamura T
    Sarcopenia in patients with cardiovascular disease.
    J Cardiol. 2020;76:636.
    PubMed    


    November 2020
  18. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
    Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
    PubMed     Abstract available


  19. CHANG WT, Lin CH, Hong CS, Liao CT, et al
    The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction.
    J Cardiol. 2020 Nov 21. pii: S0914-5087(20)30359.
    PubMed     Abstract available


  20. HATA R, Kato T, Yaku H, Morimoto T, et al
    Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
    J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
    PubMed     Abstract available


    October 2020
  21. MIRO O, Lopez-Diez MP, Rossello X, Gil V, et al
    Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate.
    J Cardiol. 2020 Oct 11. pii: S0914-5087(20)30307.
    PubMed     Abstract available


    September 2020
  22. KIMURA M, Kohno T, Sawano M, Heidenreich PA, et al
    Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention.
    J Cardiol. 2020 Sep 1. pii: S0914-5087(20)30208.
    PubMed     Abstract available


  23. KOBAYASHI S, Yoshiga Y, Yano M
    Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
    J Cardiol. 2020;76:323-324.
    PubMed    


    August 2020
  24. KWAK S, Kwon S, Lee SY, Yang S, et al
    Differential risk of incident cancer in patients with heart failure: A nationwide population-based cohort study.
    J Cardiol. 2020 Aug 28. pii: S0914-5087(20)30271.
    PubMed     Abstract available


  25. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed     Abstract available


  26. TOPAZ G, Yehezkel E, Benchetrit S, Korzets Z, et al
    Non-coronary cardiac calcifications and outcomes in patients with heart failure.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30261.
    PubMed     Abstract available


  27. NAKANE E, Kato T, Tanaka N, Kuriyama T, et al
    Association of the induction of a self-care management system with 1-year outcomes in patients hospitalized for heart failure.
    J Cardiol. 2020 Aug 2. pii: S0914-5087(20)30257.
    PubMed     Abstract available


    July 2020
  28. CAFFREY JL, Wu CK, Chang CH, Lin JW, et al
    Analysis of mortality risk following receipt of implantable cardioverter defibrillators in patients with and without heart failure.
    J Cardiol. 2020 Jul 15. pii: S0914-5087(20)30184.
    PubMed     Abstract available


  29. PHAM VT, Lin C, Tran TT, M Su MY, et al
    Predicting ventricular tachyarrhythmia in patients with systolic heart failure based on texture features of the gray zone from contrast-enhanced magnetic resonance imaging.
    J Cardiol. 2020 Jul 13. pii: S0914-5087(20)30222.
    PubMed     Abstract available


  30. TAKAGI K, Sato N, Ishihara S, Iha H, et al
    Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure.
    J Cardiol. 2020 Jul 11. pii: S0914-5087(20)30172.
    PubMed     Abstract available


  31. MITANI H, Funakubo M, Sato N, Murayama H, et al
    In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: A Japanese database cohort study.
    J Cardiol. 2020 Jul 4. pii: S0914-5087(20)30173.
    PubMed     Abstract available


  32. SAITO H, Yamashita M, Endo Y, Mizukami A, et al
    Cognitive impairment measured by Mini-Cog provides additive prognostic information in elderly patients with heart failure.
    J Cardiol. 2020 Jul 2. pii: S0914-5087(20)30210.
    PubMed     Abstract available


    June 2020
  33. NATANZON SS, Maor E, Klempfner R, Goldenberg I, et al
    Norton score and clinical outcomes following acute decompensated heart failure hospitalization.
    J Cardiol. 2020 Jun 10. pii: S0914-5087(20)30178.
    PubMed     Abstract available


    May 2020
  34. HARADA D, Asanoi H, Noto T, Takagawa J, et al
    The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction.
    J Cardiol. 2020 May 28. pii: S0914-5087(20)30163.
    PubMed     Abstract available


  35. SATO K, Takahashi J, Hao K, Miyata S, et al
    Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
    J Cardiol. 2020;75:465-472.
    PubMed     Abstract available


    April 2020
  36. NAKAGAWA Y, Kuwahara K
    Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patients.
    J Cardiol. 2020 Apr 24. pii: S0914-5087(20)30122.
    PubMed     Abstract available


  37. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    The genesis of ventricular arrhythmias in heart failure patients is based on alterations in cardiac mechanical, morphological, metabolic, electrophysiological properties, and neurohumoral remodeling.
    J Cardiol. 2020 Apr 22. pii: S0914-5087(20)30104.
    PubMed    


  38. YAMAMOTO S, Yamaga T, Nishie K, Sakai Y, et al
    Impact of physical performance on prognosis among patients with heart failure: Systematic review and meta-analysis.
    J Cardiol. 2020 Apr 11. pii: S0914-5087(20)30094.
    PubMed     Abstract available


  39. TAKAGI K, Ishihara S, Kenji N, Iha H, et al
    Clinical significance of arterial stiffness as a factor for hospitalization of heart failure with preserved left ventricular ejection fraction: a retrospective matched case-control study.
    J Cardiol. 2020 Apr 5. pii: S0914-5087(20)30069.
    PubMed     Abstract available


  40. KODZISZEWSKA K, Sochanowicz B, Smigielski W, Kruszewski M, et al
    Grey areas and open questions in neprilysin inhibition.
    J Cardiol. 2020;75:462-463.
    PubMed    


  41. CHANG HY, Yin WH
    Response to "Grey Areas and Open Questions in Neprilysin Inhibition".
    J Cardiol. 2020;75:463-464.
    PubMed    


  42. LIANG Y, Wang J, Yu Z, Zhang M, et al
    Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
    J Cardiol. 2020;75:432-438.
    PubMed     Abstract available


    March 2020
  43. SUZUKI A, Shiga T, Kawashiro N, Hagiwara N, et al
    Changes in characteristics and outcomes in Japanese patients with heart failure from the 2000s to the 2010s: The HIJ-HF cohorts.
    J Cardiol. 2020 Mar 18. pii: S0914-5087(20)30064.
    PubMed     Abstract available


  44. CHANG HY, Chen KC, Fong MC, Feng AN, et al
    Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management.
    J Cardiol. 2020;75:233-241.
    PubMed     Abstract available


    February 2020
  45. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?
    J Cardiol. 2020 Feb 27. pii: S0914-5087(20)30045.
    PubMed    


  46. DISERTORI M, Mase M, Rigoni M, Nollo G, et al
    Author's reply: "Declining clinical benefit of ICD in heart failure patients".
    J Cardiol. 2020 Feb 22. pii: S0914-5087(20)30038.
    PubMed    


  47. NISTRI S, Mazzone C, Cioffi G, Barbati G, et al
    Tissue Doppler indices of diastolic function as prognosticator in patients without heart failure in primary care.
    J Cardiol. 2020 Feb 21. pii: S0914-5087(20)30034.
    PubMed     Abstract available


  48. KAWAGUCHI J, Hamatani Y, Hirayama A, Nishimura K, et al
    Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
    J Cardiol. 2020 Feb 12. pii: S0914-5087(20)30016.
    PubMed     Abstract available


    January 2020
  49. NAKANO I, Tsuda M, Kinugawa S, Fukushima A, et al
    Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure.
    J Cardiol. 2020 Jan 27. pii: S0914-5087(20)30018.
    PubMed     Abstract available


  50. HIRAIWA H, Okumura T, Kondo T, Kato T, et al
    Usefulness of the plasma branched-chain amino acid/aromatic amino acid ratio for predicting future cardiac events in patients with heart failure.
    J Cardiol. 2020 Jan 27. pii: S0914-5087(20)30017.
    PubMed     Abstract available


    December 2019
  51. NOZAKI K, Hamazaki N, Kamiya K, Ichikawa T, et al
    Rising time from bed in acute phase after hospitalization predicts frailty at hospital discharge in patients with acute heart failure.
    J Cardiol. 2019 Dec 30. pii: S0914-5087(19)30381.
    PubMed     Abstract available


  52. KAGIYAMA Y, Yatsuga S, Kinoshita M, Koteda Y, et al
    Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt.
    J Cardiol. 2019 Dec 26. pii: S0914-5087(19)30382.
    PubMed     Abstract available


  53. KOBAYASHI S, Wakeyama T, Ono S, Ikeda Y, et al
    A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design.
    J Cardiol. 2019 Dec 19. pii: S0914-5087(19)30282.
    PubMed     Abstract available


    November 2019
  54. MAEJIMA Y
    The critical roles of protein quality control systems in the pathogenesis of heart failure.
    J Cardiol. 2019 Nov 4. pii: S0914-5087(19)30318.
    PubMed     Abstract available


    October 2019
  55. KONISHI M, Matsuzawa Y, Ebina T, Kosuge M, et al
    Impact of population density on mortality in patients hospitalized for heart failure - JROAD-DPC Registry Analysis.
    J Cardiol. 2019 Oct 9. pii: S0914-5087(19)30298.
    PubMed     Abstract available


  56. YOSHIDA R, Ishii H, Morishima I, Tanaka A, et al
    Early versus delayed invasive strategy in patients with non-ST-elevation acute coronary syndrome and concomitant congestive heart failure.
    J Cardiol. 2019;74:320-327.
    PubMed     Abstract available


    September 2019
  57. DISERTORI M, Mase M, Rigoni M, Nollo G, et al
    Declining clinical benefit of ICD in heart failure patients: Temporal trend of mortality outcomes from randomized controlled trials.
    J Cardiol. 2019 Sep 13. pii: S0914-5087(19)30171.
    PubMed     Abstract available


  58. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
    J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
    PubMed     Abstract available


  59. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
    Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
    J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
    PubMed     Abstract available


    August 2019
  60. TOYODA S, Haruyama A, Inami S, Arikawa T, et al
    Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure.
    J Cardiol. 2019 Aug 21. pii: S0914-5087(19)30237.
    PubMed     Abstract available


  61. KONO Y, Izawa H, Aoyagi Y, Ishikawa A, et al
    The difference in determinant factor of six-minute walking distance between sarcopenic and non-sarcopenic elderly patients with heart failure.
    J Cardiol. 2019 Aug 3. pii: S0914-5087(19)30207.
    PubMed     Abstract available


    July 2019
  62. MASSARI F, Scicchitano P, Iacoviello M, Passantino A, et al
    Multiparametric approach to congestion for predicting long-term survival in heart failure.
    J Cardiol. 2019 Jul 17. pii: S0914-5087(19)30179.
    PubMed     Abstract available


  63. HIEBERT JB, Vacek J, Shah Z, Rahman F, et al
    Use of speckle tracking to assess heart failure with preserved ejection fraction.
    J Cardiol. 2019 Jul 11. pii: S0914-5087(19)30174.
    PubMed     Abstract available


  64. LI HQ, Wang N, Chen Y
    Association between the activities of daily living and clinical outcomes in patients with heart failure.
    J Cardiol. 2019 Jul 9. pii: S0914-5087(19)30154.
    PubMed    


  65. EZAKI H, Ayaori M, Sato H, Maeno Y, et al
    Effects of Mokuboito, a Japanese Kampo medicine, on symptoms in patients hospitalized for acute decompensated heart failure - A prospective randomized pilot study.
    J Cardiol. 2019 Jul 2. pii: S0914-5087(19)30141.
    PubMed     Abstract available


    June 2019
  66. YAMASHITA T, Nakasu Y, Mizutani H, Sumitani K, et al
    A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
    J Cardiol. 2019 Jun 26. pii: S0914-5087(19)30153.
    PubMed     Abstract available


  67. EJIRI K, Noriyasu T, Nakamura K, Ito H, et al
    Unprecedented crisis-Heart failure hospitalizations in current or future Japan.
    J Cardiol. 2019 Jun 26. pii: S0914-5087(19)30145.
    PubMed    


  68. TAKABAYASHI K
    Author's reply: A decline in activities of daily living due to acute heart failure is an independent risk factor of hospitalization for heart failure and mortality.
    J Cardiol. 2019 Jun 21. pii: S0914-5087(19)30127.
    PubMed    


    May 2019
  69. GOURRONC Y, Grall S, Ingremeau D, Desprets L, et al
    De novo atrial fibrillation as an independent prognostic marker after ST-segment elevation myocardial infarction: Results from the RIMA registry.
    J Cardiol. 2019 May 9. pii: S0914-5087(19)30040.
    PubMed     Abstract available


  70. NAKASHIMA A, Miyoshi T, Aoki-Kamiya C, Nishio M, et al
    Predicting postpartum cardiac events in pregnant women with complete atrioventricular block.
    J Cardiol. 2019 May 3. pii: S0914-5087(19)30099.
    PubMed     Abstract available


    April 2019
  71. WATANABE T
    Is rhythm control superior to rate control in patients with heart failure and preserved ejection fraction?
    J Cardiol. 2019 Apr 24. pii: S0914-5087(19)30102.
    PubMed    


  72. FERRI-CERTIC J, Zavrl-Dzananovic D, Lezaic L, Zizek D, et al
    Impact of left ventricular pacing threshold on ventricular arrhythmia occurrence in cardiac resynchronization therapy.
    J Cardiol. 2019 Apr 13. pii: S0914-5087(19)30087.
    PubMed     Abstract available


  73. CHANG HY, Feng AN, Fong MC, Hsueh CW, et al
    Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation.
    J Cardiol. 2019 Apr 11. pii: S0914-5087(19)30082.
    PubMed     Abstract available


  74. UEHARA K, Yamamoto Y, Hatsuse S, Isotani Y, et al
    Systolic blood pressure on admission as a marker of fluid re-distribution in acute heart failure.
    J Cardiol. 2019 Apr 3. pii: S0914-5087(19)30063.
    PubMed     Abstract available


    March 2019
  75. MACHINO-OHTSUKA T, Seo Y, Ishizu T, Yamamoto M, et al
    Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    J Cardiol. 2019 Mar 22. pii: S0914-5087(19)30057.
    PubMed     Abstract available


  76. GOLDSMITH SR
    Arginine vasopressin antagonism in heart failure: Current status and possible new directions.
    J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053.
    PubMed     Abstract available


    February 2019
  77. SHITARA J, Kasai T, Akihiro S, Yatsu S, et al
    Effects of suvorexant on sleep apnea in patients with heart failure: A protocol of crossover pilot trial.
    J Cardiol. 2019 Feb 5. pii: S0914-5087(19)30008.
    PubMed     Abstract available


  78. SATO Y, Yoshihisa A, Oikawa M, Nagai T, et al
    Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    J Cardiol. 2019 Feb 1. pii: S0914-5087(19)30010.
    PubMed     Abstract available


  79. KITAOKA H
    Author's reply.
    J Cardiol. 2019;73:186.
    PubMed    


    January 2019
  80. NAMISAKI H, Nagata Y, Seo Y, Ishizu T, et al
    Symptomatic paradoxical low gradient severe aortic stenosis: A possible link to heart failure with preserved ejection fraction.
    J Cardiol. 2019 Jan 4. pii: S0914-5087(18)30370.
    PubMed     Abstract available


    December 2018
  81. ABE R, Sakata Y, Nochioka K, Miura M, et al
    Gender differences in prognostic relevance of self-care behaviors on mortality and hospitalization in patients with heart failure - A report from the CHART-2 Study.
    J Cardiol. 2018 Dec 31. pii: S0914-5087(18)30331.
    PubMed     Abstract available


  82. TAKABAYASHI K, Kitaguchi S, Iwatsu K, Morikami Y, et al
    A decline in activities of daily living due to acute heart failure is an independent risk factor of hospitalization for heart failure and mortality.
    J Cardiol. 2018 Dec 28. pii: S0914-5087(18)30367.
    PubMed     Abstract available


  83. YOSHIKAWA Y, Shiomi H, Kuwahara K, Sowa N, et al
    Utility of copeptin for predicting long-term clinical outcomes in patients with heart failure.
    J Cardiol. 2018 Dec 24. pii: S0914-5087(18)30335.
    PubMed     Abstract available


  84. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Impact of stroke volume on prognostic outcome in patients with atrial fibrillation and concomitant heart failure with preserved ejection fraction.
    J Cardiol. 2018 Dec 22. pii: S0914-5087(18)30354.
    PubMed     Abstract available


  85. SUGANO A, Seo Y, Ishizu T, Sai S, et al
    Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction.
    J Cardiol. 2018 Dec 20. pii: S0914-5087(18)30359.
    PubMed     Abstract available


    November 2018
  86. ISOMI M, Sadahiro T, Ieda M
    Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.
    J Cardiol. 2018 Nov 9. pii: S0914-5087(18)30287.
    PubMed     Abstract available


  87. JOHO S, Ushijima R, Nakagaito M, Kinugawa K, et al
    Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failure.
    J Cardiol. 2018 Nov 9. pii: S0914-5087(18)30286.
    PubMed     Abstract available


    October 2018
  88. AKASHI M, Minami Y, Haruki S, Jujo K, et al
    Prognostic implications of prealbumin level on admission in patients with acute heart failure referred to a cardiac intensive care unit.
    J Cardiol. 2018 Oct 23. pii: S0914-5087(18)30262.
    PubMed     Abstract available


  89. LIM NK, Lee SE, Lee HY, Cho HJ, et al
    Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.
    J Cardiol. 2018 Oct 22. pii: S0914-5087(18)30266.
    PubMed     Abstract available


  90. SANO M
    Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk.
    J Cardiol. 2018 Oct 11. pii: S0914-5087(18)30231.
    PubMed     Abstract available


    August 2018
  91. BANDYOPADHYAY D, Ashish K, Dhaduk K, Banerjee U, et al
    Role of liver stiffness in prediction of adverse outcomes in heart failure.
    J Cardiol. 2018 Aug 31. pii: S0914-5087(18)30234.
    PubMed    


  92. MIYAGAWA S, Sawa Y
    Building a new strategy for treating heart failure using Induced Pluripotent Stem Cells.
    J Cardiol. 2018 Aug 29. pii: S0914-5087(18)30133.
    PubMed     Abstract available


    July 2018
  93. FUJIWARA W, Kato Y, Hayashi M, Sugishita Y, et al
    Serum microRNA-126 and -223 as new-generation biomarkers for sarcoidosis in patients with heart failure.
    J Cardiol. 2018 Jul 24. pii: S0914-5087(18)30182.
    PubMed     Abstract available


    June 2018
  94. TSUJI S, Koyama S, Taniguchi R, Fujiwara T, et al
    Nutritional status of outpatients with chronic stable heart failure based on serum amino acid concentration.
    J Cardiol. 2018 Jun 6. pii: S0914-5087(18)30142.
    PubMed     Abstract available


    May 2018
  95. SAITO C, Minami Y, Arai K, Haruki S, et al
    Prevalence, clinical characteristics, and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation.
    J Cardiol. 2018 May 8. pii: S0914-5087(18)30108.
    PubMed     Abstract available


    March 2018
  96. ICHIJO S, Miyazaki S, Kusa S, Nakamura H, et al
    Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    J Cardiol. 2018 Mar 30. pii: S0914-5087(18)30063.
    PubMed     Abstract available


  97. OGURI M, Ishii H, Ohguchi S, Takahara K, et al
    Comparison of two dosing methods for immediate administration of tolvaptan in acute decompensated heart failure.
    J Cardiol. 2018 Mar 19. pii: S0914-5087(18)30052.
    PubMed     Abstract available


  98. STIEGER P, Rana OR, Saygili E, Zazai H, et al
    Impact of internal and external electrical cardioversion on cardiac specific enzymes and inflammation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2018 Mar 12. pii: S0914-5087(18)30048.
    PubMed     Abstract available


  99. MATSUSHITA M, Shirakabe A, Hata N, Kobayashi N, et al
    Social determinants are crucial factors in the long-term prognosis of severely decompensated acute heart failure in patients over 75 years of age.
    J Cardiol. 2018 Mar 6. pii: S0914-5087(18)30033.
    PubMed     Abstract available


  100. YAMAZOE M, Mizuno A, Kohsaka S, Shiraishi Y, et al
    Incidence of hospital-acquired hyponatremia by the dose and type of diuretics among patients with acute heart failure and its association with long-term outcomes.
    J Cardiol. 2018 Mar 5. pii: S0914-5087(17)30270.
    PubMed     Abstract available


    February 2018
  101. SANO M
    A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity.
    J Cardiol. 2018 Feb 4. pii: S0914-5087(17)30347.
    PubMed     Abstract available


    January 2018
  102. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
    J Cardiol. 2018 Jan 18. pii: S0914-5087(18)30003.
    PubMed     Abstract available


    December 2017
  103. SAKAGUCHI T, Watanabe M, Kawasaki C, Kuroda I, et al
    A novel scoring system to predict delirium and its relationship with the clinical course in patients with acute decompensated heart failure.
    J Cardiol. 2017 Dec 26. pii: S0914-5087(17)30341.
    PubMed     Abstract available


  104. HORIUCHI Y, Tanimoto S, Okuno T, Aoki J, et al
    Hemodynamic correlates of nutritional indexes in heart failure.
    J Cardiol. 2017 Dec 2. pii: S0914-5087(17)30327.
    PubMed     Abstract available


  105. KAMIMURA D, Suzuki T, Hall ME, Wang W, et al
    Diastolic wall strain is associated with incident heart failure in African Americans: Insights from the atherosclerosis risk in communities study.
    J Cardiol. 2017 Dec 1. pii: S0914-5087(17)30325.
    PubMed     Abstract available


    November 2017
  106. FUKUSHIMA A, Kinugawa S
    Hyponatremia as a surrogate marker for optimal diuretic selection in acute heart failure.
    J Cardiol. 2017 Nov 20. pii: S0914-5087(17)30303.
    PubMed    


    October 2017
  107. LI L, Jesdale BM, Hume A, Gambassi G, et al
    Who are they? Patients with heart failure in American skilled nursing facilities.
    J Cardiol. 2017 Oct 27. pii: S0914-5087(17)30254.
    PubMed     Abstract available


    September 2017
  108. KUMAGAI N, Dohi K, Fujimoto N, Tanimura M, et al
    A novel method for the quantitative evaluation of diurnal respiratory instability in patients with heart failure: A pilot study.
    J Cardiol. 2017 Sep 25. pii: S0914-5087(17)30218.
    PubMed     Abstract available


    August 2017
  109. KUROZUMI Y, Oishi S, Sugano Y, Sakashita A, et al
    Design of a nationwide survey on palliative care for end-stage heart failure in Japan.
    J Cardiol. 2017 Aug 22. pii: S0914-5087(17)30196.
    PubMed     Abstract available


    July 2017
  110. LEE NS, Lin F, Birgersdotter-Green U
    Should women have different ECG criteria for CRT than men?
    J Cardiol. 2017;70:1-6.
    PubMed     Abstract available


    June 2017
  111. MIYOSHI A, Nishii N, Kubo M, Okamoto Y, et al
    An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial st
    J Cardiol. 2017 Jun 30. pii: S0914-5087(17)30156.
    PubMed     Abstract available


  112. SAWAMURA A, Okumura T, Hiraiwa H, Aoki S, et al
    Cholesterol metabolism as a prognostic marker in patients with mildly symptomatic nonischemic dilated cardiomyopathy.
    J Cardiol. 2017;69:888-894.
    PubMed     Abstract available


    May 2017
  113. YANG LT, Kado Y, Nagata Y, Otani K, et al
    Timing on echocardiography and blood laboratory test is important for future outcome association in hospitalized heart failure patients.
    J Cardiol. 2017 May 22. pii: S0914-5087(17)30114.
    PubMed     Abstract available


  114. HOSODA J, Ishikawa T, Matsumoto K, Iguchi K, et al
    Significance of change in serum bilirubin in predicting left ventricular reverse remodeling and outcomes in heart failure patients with cardiac resynchronization therapy.
    J Cardiol. 2017 May 15. pii: S0914-5087(17)30096.
    PubMed     Abstract available


  115. IMAI R, Uemura Y, Okumura T, Takemoto K, et al
    Impact of red blood cell distribution width on non-cardiac mortality in patients with acute decompensated heart failure with preserved ejection fraction.
    J Cardiol. 2017 May 15. pii: S0914-5087(17)30098.
    PubMed     Abstract available


    April 2017
  116. ASANOI H, Harada D, Oda Y, Ueno H, et al
    Independent prognostic importance of respiratory instability and sympathetic nerve activity in patients with chronic heart failure.
    J Cardiol. 2017 Apr 21. pii: S0914-5087(17)30088.
    PubMed     Abstract available


    March 2017
  117. KAWATA T, Daimon M, Kimura K, Nakao T, et al
    Echocardiographic assessment of right ventricular function in routine practice: Which parameters are useful to predict one-year outcome in advanced heart failure patients with dilated cardiomyopathy?
    J Cardiol. 2017 Mar 21. pii: S0914-5087(17)30061.
    PubMed     Abstract available


  118. WANG CH, Cheng ML, Liu MH, Kuo LT, et al
    Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    J Cardiol. 2017 Mar 16. pii: S0914-5087(16)30244.
    PubMed     Abstract available


    February 2017
  119. OKAZAKI H, Shirakabe A, Otsuka T, Kobayashi N, et al
    Response to letter regarding article, "The prognostic impact of uric acid in patients with severely decompensated acute heart failure".
    J Cardiol. 2017 Feb 25. pii: S0914-5087(17)30021.
    PubMed    


  120. PAKZAD R, Ashrafi-Asgarabad A, Safiri S
    The prognostic impact of uric acid in patients with severely decompensated acute heart failure; Methodological issues.
    J Cardiol. 2017 Feb 23. pii: S0914-5087(17)30022.
    PubMed    


  121. SUGANO A, Seo Y, Yamamoto M, Harimura Y, et al
    Optimal cut-off value of reverse remodeling to predict long-term outcome after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    J Cardiol. 2017;69:456-461.
    PubMed     Abstract available


  122. KUWATA S, Yoneyama K, Suzuki K, Izumo M, et al
    Aortic annulus displacement assessed by contrast left ventriculography during invasive coronary angiography as a predictor of adverse events.
    J Cardiol. 2017;69:442-448.
    PubMed     Abstract available


    January 2017
  123. SUMITOMO N, Horigome H, Miura M, Ono H, et al
    Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
    J Cardiol. 2017 Jan 7. pii: S0914-5087(16)30343.
    PubMed     Abstract available


  124. KUBO T, Ochi Y, Baba Y, Hirota T, et al
    Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
    J Cardiol. 2017;69:302-307.
    PubMed     Abstract available


  125. IZUMO M, Takeuchi M, Seo Y, Yamashita E, et al
    Prognostic implications in patients with symptomatic aortic stenosis and preserved ejection fraction: Japanese multicenter aortic stenosis, retrospective (JUST-R) registry.
    J Cardiol. 2017;69:110-118.
    PubMed     Abstract available


    December 2016
  126. NOZAKI A, Shirakabe A, Hata N, Kobayashi N, et al
    The prognostic impact of gender in patients with acute heart failure - An evaluation of the age of female patients with severely decompensated acute heart failure.
    J Cardiol. 2016 Dec 28. pii: S0914-5087(16)30316.
    PubMed     Abstract available


  127. TSUTSUI H, Momomura S, Saito Y, Ito H, et al
    Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study.
    J Cardiol. 2016 Dec 23. pii: S0914-5087(16)30309.
    PubMed     Abstract available


    May 2016
  128. CHO SW, Hwang JK, Chun KJ, Park SJ, et al
    Impact of moderate to severe renal impairment on long-term clinical outcomes in patients with atrial fibrillation.
    J Cardiol. 2016 May 25. pii: S0914-5087(16)30055.
    PubMed     Abstract available


    April 2016
  129. SAKAMOTO T, Ogawa H, Nakao K, Hokimoto S, et al
    Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial.
    J Cardiol. 2016;67:371-7.
    PubMed     Abstract available


    August 2015
  130. IBE T, Wada H, Sakakura K, Ikeda N, et al
    Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
    J Cardiol. 2015 Aug 20. pii: S0914-5087(15)00228.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: